<http://webisa.webdatacommons.org/prov/408368315> <http://www.w3.org/ns/prov#wasDerivedFrom> <http://webisa.webdatacommons.org/1033772> . <http://webisa.webdatacommons.org/1033772> <http://www.w3.org/ns/prov#wasQuotedFrom> <researchgate.net> . <http://webisa.webdatacommons.org/1033772> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/ns/prov#Entity> . <http://webisa.webdatacommons.org/1033772> <http://www.w3.org/ns/prov#value> "shing a 7-T sitein an EU country, the ongoing debate regarding the Directiveand its future implementation in the member states iscarefully monitored.Costs of installation, system hardware and running a 7-TMR systemCurrently, i.e. mid-2011, the installation of a second-generation,actively shielded, 7-T whole-body system requires an equipment7-T MR???FROM RESEARCH TO CLINIC?NMR Biomed. 2012; 25: 695" .